Markets
BSE See NSE See 37,363.43
809.83 (2.22%)
Laurus Labs Limited : In A Healthy Space

Laurus Labs Limited : In A Healthy Space

Print

India is considered to be one of the largest providers of quality, affordable generic drugs globally and Laurus Labs occupies a position of prime significance in this segment  

To read the entire article, you must be a DSIJ magazine subscriber.

 
 

 

Comments are only visible to subscribers.

DSIJ Mindshare

Cipla gets final nod for generic therapeutic equivalent of Tecfidera; stock opens 1.52 per cent higher

rishikesh gaikwad / Article rating: 3.7

Cipla Limited today announced that it has received final approval for its abbreviated new drug application (ANDA) for Dimethyl Fumarate DR Capsules 120mg, 240mg, and 120mg/240mg starter pack from United States Food & Drug Administration (USFDA).

12345Last